Ignite Creation Date:
2025-12-25 @ 12:02 AM
Ignite Modification Date:
2025-12-25 @ 9:59 PM
Study NCT ID:
NCT03906058
Status:
COMPLETED
Last Update Posted:
2023-10-25
First Post:
2019-04-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy
Sponsor:
Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-29
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-30
Completion Date Type:
ACTUAL
First Submit Date:
2019-04-05
First Submit QC Date:
None
Study First Post Date:
2019-04-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-22
Last Update Post Date:
2023-10-25
Last Update Post Date Type:
ACTUAL